Access to Diagnostics
About Access to Diagnostics
Data last updated:
Access to Diagnostics is a private not for profit company based in New, Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 17 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013NPL252206.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yogita Kumar and Divye Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at K – 69, 3rd Floor, New, Delhi, India – 110016.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressK – 69, 3rd Floor, New, Delhi, India – 110016
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Access to Diagnostics FY 2025 filings available
Access to Diagnostics reported revenue of ₹364 (down 100% YoY) for FY 2025.
Financial Statement Summary of Access to Diagnostics
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Access to Diagnostics
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Access to Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Access to Diagnostics
Access to Diagnostics is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Satyashrey Foundation | •••• | •••• | •••• | •••• | - | Muzaffarpur, Bihar, India |
| RX Foundation | •••• | •••• | •••• | •••• | - | Faridabad, Haryana, India |
| Bharat Telepharma Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| Oshellare Health Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Santoshi Medicals Private Limited | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Access to Diagnostics this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Atlanta Polyclinic Private Limited | •••• | •••• | •••• | •••• | - | Nagpur, Maharashtra, India |
| Balaji Confederate Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Prithasavi Chhikitsa Private Limited | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Satyawrat Seeds Solutions Private Limited | •••• | •••• | •••• | •••• | - | Kota, Rajasthan, India |
| Prime Medical Alliance Private Limited | •••• | •••• | •••• | •••• | - | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Access to Diagnostics by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Access to Diagnostics
Access to Diagnostics is audited by ADARSH SHARMA & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ADARSH SHARMA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Access to Diagnostics
Access to Diagnostics has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dayashankar Vidyalankar | Additional Director | 16 Feb 2022 | 4 Years 7 Months | Current |
| Yogita Kumar Also directs: Dr Chhabra Pathology Centre LLP | Director | 17 May 2013 | 13 Years 4 Months | Current |
| Divye Chhabra Also directs: Dr Chhabra Pathology Centre LLP | Director | 17 May 2013 | 13 Years 4 Months | Current |
| Vandana Kumar | Director | 17 May 2013 | 13 Years 4 Months | Current |
Ownership and Shareholding of Access to Diagnostics
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Access to Diagnostics
Access to Diagnostics does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Access to Diagnostics
Employment history and EPFO contributions of people linked to Access to Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Access to Diagnostics
Access to Diagnostics has 5 board changes on record since 2013: 4 appointments and 1 cessation. The latest: Kedar Nath Chhabra ceased to be Director on 12 Apr 2023.
Credit Ratings, Litigation & Regulatory Alerts for Access to Diagnostics
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Access to Diagnostics
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Access to Diagnostics
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Access to Diagnostics
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Access to Diagnostics
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Access to Diagnostics
Access to Diagnostics is an active private not for profit company based in New, Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 17 May 2013 (13+ years old) and is registered under CIN U85100DL2013NPL252206.
Access to Diagnostics has 4 current directors:
- Dayashankar Vidyalankar - Additional Director
- Yogita Kumar - Director
- Divye Chhabra - Director
- Vandana Kumar - Director
The CIN (Corporate Identification Number) of Access to Diagnostics is U85100DL2013NPL252206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Access to Diagnostics was incorporated on 17 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Access to Diagnostics by revenue are Satyashrey Foundation, RX Foundation, Bharat Telepharma Private Limited, Oshellare Health Private Limited, Santoshi Medicals Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Kedar Nath Chhabra ceased to be Director on 12 Apr 2023. Dayashankar Vidyalankar was appointed as Additional Director on 16 Feb 2022. Divye Chhabra was appointed as Director on 17 May 2013. Access to Diagnostics has 5 board changes on record in total.
The registered office of Access to Diagnostics is at K – 69, 3rd Floor, New, Delhi, India – 110016.
Access to Diagnostics has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Access to Diagnostics operates in the healthcare industry, in the preventive health services segment.
No. Access to Diagnostics is not listed on any stock exchange. It is an unlisted company.
The compliance status of Access to Diagnostics is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.